MERTK and breast carcinoma: On the other hand, among breast cancer, we found seven out of eight invasive ductal carcinomas (Figure 2A) and four out of eight invasive lobular carcinomas (Figure 2B) presenting a positive staining for MerTK in immune infiltrate.